HISTONE DEACETYLASES IN BONE DEVELOPMENT AND SKELETAL DISORDERS

被引:140
作者
Bradley, Elizabeth W.
Carpio, Lomeli R.
van Wijnen, Andre J.
McGee-Lawrence, Meghan E.
Westendorf, Jennifer J.
机构
[1] Mayo Clin, Dept Orthoped Surg, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA
[3] Mayo Grad Sch, Rochester, MN USA
[4] Georgia Regents Univ, Dept Cellular Biol & Anat, Augusta, GA USA
基金
美国国家卫生研究院;
关键词
MESENCHYMAL STEM-CELLS; CONTROLS CHONDROCYTE HYPERTROPHY; MENTAL-RETARDATION SYNDROME; HDAC INHIBITOR; TRANSCRIPTIONAL REPRESSOR; GENE-EXPRESSION; N-COR; SUPPRESSES OSTEOCLASTOGENESIS; OSTEOGENIC DIFFERENTIATION; OSTEOBLAST MATURATION;
D O I
10.1152/physrev.00004.2015
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Histone deacetylases (Hdacs) are conserved enzymes that remove acetyl groups from lysine side chains in histones and other proteins. Eleven of the 18 Hdacs encoded by the human and mouse genomes depend on Zn2+ for enzymatic activity, while the other 7, the sirtuins (Sirts), require NAD2(+). Collectively, Hdacs and Sirts regulate numerous cellular and mitochondrial processes including gene transcription, DNA repair, protein stability, cytoskeletal dynamics, and signaling pathways to affect both development and aging. Of clinical relevance, Hdacs inhibitors are United States Food and Drug Administration-approved cancer therapeutics and are candidate therapies for other common diseases including arthritis, diabetes, epilepsy, heart disease, HIV infection, neurodegeneration, and numerous aging-related disorders. Hdacs and Sirts influence skeletal development, maintenance of mineral density and bone strength by affecting intramembranous and endochondral ossification, as well as bone resorption. With few exceptions, inhibition of Hdac or Sirt activity though either loss-of-function mutations or prolonged chemical inhibition has negative and/or toxic effects on skeletal development and bone mineral density. Specifically, Hdac/Sirt suppression causes abnormalities in physiological development such as craniofacial dimorphisms, short stature, and bone fragility that are associated with several human syndromes or diseases. In contrast, activation of Sirts may protect the skeleton from aging and immobilization-related bone loss. This knowledge may prolong healthspan and prevent adverse events caused by epigenetic therapies that are entering the clinical realm at an unprecedented rate. In this review, we summarize the general properties of Hdacs/Sirts and the research that has revealed their essential functions in bone forming cells (e.g., osteoblasts and chondrocytes) and bone resorbing osteoclasts. Finally, we offer predictions on future research in this area and the utility of this knowledge for orthopedic applications and bone tissue engineering.
引用
收藏
页码:1359 / 1381
页数:23
相关论文
共 220 条
[1]   Low sirtuin 1 levels in human osteoarthritis subchondral osteoblasts lead to abnormal sclerostin expression which decreases Wnt/β-catenin activity [J].
Abed, Elie ;
Couchourel, Denis ;
Delalandre, Aline ;
Duval, Nicholas ;
Pelletier, Jean-Pierre ;
Martel-Pelletier, Johanne ;
Lajeunesse, Daniel .
BONE, 2014, 59 :28-36
[2]  
[Anonymous], HISTONE DEACETYLASE
[3]   MEF2C transcription factor controls chondrocyte hypertrophy and bone development [J].
Arnold, Michael A. ;
Kim, Yuri ;
Czubryt, Michael P. ;
Phan, Dillon ;
McAnally, John ;
Qi, Xiaoxia ;
Shelton, John M. ;
Richardson, James A. ;
Bassel-Duby, Rhonda ;
Olson, Eric N. .
DEVELOPMENTAL CELL, 2007, 12 (03) :377-389
[4]   The Sirtuin1 Activator SRT3025 Down-Regulates Sclerostin and Rescues Ovariectomy-Induced Bone Loss and Biomechanical Deterioration in Female Mice [J].
Artsi, Hanna ;
Cohen-Kfir, Einav ;
Gurt, Irina ;
Shahar, Ron ;
Bajayo, Alon ;
Kalish, Noga ;
Bellido, Teresita M. ;
Gabet, Yankel ;
Dresner-Pollak, Rivka .
ENDOCRINOLOGY, 2014, 155 (09) :3508-3515
[5]   Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes [J].
Bantscheff, Marcus ;
Hopf, Carsten ;
Savitski, Mikhail M. ;
Dittmann, Antje ;
Grandi, Paola ;
Michon, Anne-Marie ;
Schlegl, Judith ;
Abraham, Yann ;
Becher, Isabelle ;
Bergamini, Giovanna ;
Boesche, Markus ;
Delling, Manja ;
Duempelfeld, Birgit ;
Eberhard, Dirk ;
Huthmacher, Carola ;
Mathieson, Toby ;
Poeckel, Daniel ;
Reader, Valerie ;
Strunk, Katja ;
Sweetman, Gavain ;
Kruse, Ulrich ;
Neubauer, Gitte ;
Ramsden, Nigel G. ;
Drewes, Gerard .
NATURE BIOTECHNOLOGY, 2011, 29 (03) :255-U124
[6]   Visualization of cartilage formation: Insight into cellular properties of skeletal progenitors and chondrodysplasia syndromes [J].
Barna, Maria ;
Niswander, Lee .
DEVELOPMENTAL CELL, 2007, 12 (06) :931-941
[7]   Deletion of histone deacetylase 3 reveals critical roles in S phase progression and DNA damage control [J].
Bhaskara, Srividya ;
Chyla, Brenda J. ;
Amann, Joseph M. ;
Knutson, Sarah K. ;
Cortez, David ;
Sun, Zu-Wen ;
Hiebert, Scott W. .
MOLECULAR CELL, 2008, 30 (01) :61-72
[8]   BIOCHEMISTRY Sirtuin on a high-fat diet [J].
Bheda, Poonam ;
Wolberger, Cynthia .
NATURE, 2013, 496 (7443) :41-42
[9]   The Sir2 family of protein deacetylases [J].
Blander, G ;
Guarente, L .
ANNUAL REVIEW OF BIOCHEMISTRY, 2004, 73 :417-435
[10]   The effect of valproate on bone mineral density in adult epileptic patients [J].
Boluk, A ;
Guzelipek, M ;
Savli, H ;
Temel, I ;
Ozisik, HI ;
Kaygusuz, A .
PHARMACOLOGICAL RESEARCH, 2004, 50 (01) :93-97